Scientific Sessions 2025  /  Personalized, Potent, and Precise: The Evolving Drug Landscape in AMI  /  Next-Gen Antiplatelet and Anticoagulant Therapies in AMI: Moving Beyond the Standard of Care
Logo

American Heart Association

  42
  0

Final ID:

Next-Gen Antiplatelet and Anticoagulant Therapies in AMI: Moving Beyond the Standard of Care

  • Rymer, Jennifer  ( Duke , Chapel Hill , North Carolina , United States )
    • Author Disclosures:
    Jennifer Rymer: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Personalized, Potent, and Precise: The Evolving Drug Landscape in AMI

Monday, 11/10/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
Frontline Pharmaco-Tactics: Optimizing Pre-Hospital and Early In-Hospital Medication in STEMI

Cohen Mauricio, Tarantini Giuseppe

Precision Medicine in AMI Care: Pharmacogenomics and Personalized Therapy

Defilippi Christopher

More abstracts from these authors:
How Artificial Intelligence (AI) can help address disparities in vascular care.

Ross Elsie, Rymer Jennifer

The Role of Implementation Science and Pragmatic Trials: Adapting to patient needs

Minc Samantha, Rymer Jennifer, Weissler E.

You have to be authorized to contact abstract author. Please, Login
Not Available